scholarly journals The Association Between Risk Factors for Metabolic Syndrome and Meibomian Gland Disease in a Dry Eye Cohort

2021 ◽  
Vol Volume 15 ◽  
pp. 3821-3832
Author(s):  
Natalia Mussi ◽  
Waqas Haque ◽  
Danielle M Robertson
Keyword(s):  
Risk Factors ◽  
Metabolic Syndrome ◽  
Dry Eye ◽  
Meibomian Gland ◽  
Meibomian Gland Disease

TEAR FILM EVALUATION IN CASES OF PARKINSON’S DISEASE

2021 ◽  
pp. 22-24
Author(s):  
V. Meenakshi ◽  
Saswathi Bhushan ◽  
T. Jyothirmayi
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Dry Eye ◽  
Meibomian Gland ◽  
Blink Rate ◽  
Eye Symptoms ◽  
Tear Meniscus ◽  
Tear Meniscus Height ◽  
Dry Eye Symptoms ◽  
Meibomian Gland Disease

AIM: To evaluate tear lm status in cases of Parkinson's Disease and compare with a study group METHODS:50 patients of Parkinson's Disease and 50 age-gender matched controls were included in this study. Both groups underwent detailed history regarding dry eye symptoms,tear lm evaluation using slit-lamp bio-microscopy, uorescein staining, tear meniscus height, tear breakup time, Schirmer test, blink rate. Statistical analysis was done with Statistical Package for Social Sciences [SPSS] - Version 22.0 Released 2013 version RESULTS: There was a signicant difference between the various groups in terms of distribution of Meibomian Gland Disease 72.0% of the Case group as compared to 40% of control group had Meibomian Gland Disease,There was a signicant difference between the various groups in terms of distribution of Tear Meniscus Height <0.25Mm , Case group had the larger proportion of Tear Meniscus Height of <0.25Mm .There was a signicant difference between the various groups in terms of distribution of Tear Breakup Time <5 Sec, Schirmer's Test <5Mm in 5Min and Blink Rate <10 .There was no signicant difference between the various groups in terms of distribution of corneal Staining and dry eye symptoms. CONCLUSION: The study concluded that patient of Parkinson's disease had higher dry eye symptoms and Meibomian gland disease Also they have reduced Tear miniscus height,Tear lm break up time,Schirmer test I and Blink rate

Association of tear proteins with Meibomian gland disease and dry eye symptoms

2010 ◽  
Vol 95 (6) ◽  
pp. 848-852 ◽  
Author(s):  
L. Tong ◽  
L. Zhou ◽  
R. W. Beuerman ◽  
S. Z. Zhao ◽  
X. R. Li
Keyword(s):  
Dry Eye ◽  
Meibomian Gland ◽  
Tear Proteins ◽  
Eye Symptoms ◽  
Dry Eye Symptoms ◽  
Meibomian Gland Disease

scholarly journals Efficacy of Self-Administration of a Personal Mechanical Eyelid Device for the Treatment of Dry Eye Disease, Blepharitis and Meibomian Gland Disease

2020 ◽  
Vol 3 (1) ◽  
pp. e1-e5
Author(s):  
David Schanzlin ◽  
John Olkowski ◽  
John Coble ◽  
Wendy Gross ◽  
Michael Dash
Keyword(s):  
Adverse Events ◽  
Dry Eye ◽  
Training Session ◽  
Meibomian Gland ◽  
Dry Eye Disease ◽  
Eye Disease ◽  
Self Administration ◽  
Staining Score ◽  
Meibomian Gland Disease ◽  
At Home

PurposeA prospective study to evaluate the safety and efficacy of a novel mechanical eyelid device (NuLidsTM by NuSight Medical, LLC, Rancho Santa Fe, CA) used at home for the treatment of dry eye disease (DED), blepharitis (anterior and posterior) and meibomian gland disease (MGD). MethodsSeventy-four (74) eyes of thirty-seven (37) patients were self-treated with the NuLidsTM device at home. Inclusion criteria included blepharitis, MGD and/or DED. After an initial training session, each eyelid was treated for 15 seconds (total of 1 minute per treatment session per day). The following tests were collected before the first treatment and after the final treatment: OSDI survey, BCVA, Tear Osmolarity Test (Tear Lab), Tear Break Up Time (TBUT), Meibomian Gland Score (MGS), Meibomian Glands Yielding Liquid Secre-tions (MGYLS), Sicca Ocular Staining Score. Satisfaction with treatment survey was taken after treatment. ResultsAll measured parameters had a statistically significant improvement. Symptoms improved based on an average decrease in OSDI score from 54.2 ± 19.5 (mean ± SD) to 26.7 ± 18.4 (P < 0.001). Tear osmolarity improved from 315 ± 15.7 to 306 ± 13.9 (P = 0.002). TBUT was noted to improve from pre-treatment of 4.8 ± 1.7 seconds to post-treatment of 7.9 ± 4.1 seconds (P < 0.001). MGS improved from 8.9 ± 5.1 to 7.0 ± 5.9 (P = 0.01). MGYLS improved from 8.7 ± 6.2 to 15.8 ± 6.9 (P = 0.002). Sicca Ocular Staining Score improved from 2.7 ± 2.1 to 1.4 ± 1.5 (P = 0.002).There were no adverse events. No corneal or conjunctival trauma. No patients dropped out of the trial due to discomfort. 91% of participants agreed or strongly agreed that the device was easy and convenient to use. Of those previously using manual lid scrubs, 82% felt the NuLids device was easier and more comfortable to use. 89% described little or no discomfort. 95% were satisfied or very satisfied with the overall treatment. ConclusionsA mechanical device was safely used by patients at home for 1 minute daily for 30 days to treat DED, blepharitis, and MGD. There was a statistically significant improvement in signs and symptoms of DED as shown by improved OSDI, tear osmolarity, TBUT, MGS, MGYLS, and Ocular Staining Score. High patient satisfaction along with the low risk of adverse events supports the use of this device as a valid tool to treat DED, blepharitis, and MGD.

scholarly journals Dry Eye Due To Millet Diabetes

2021 ◽  
Vol 1 (2) ◽  
pp. 139-146
Author(s):  
Rizka Febriya Moestafa
Keyword(s):  
Diabetes Mellitus ◽  
Risk Factors ◽  
Dry Eye ◽  
Systemic Disease ◽  
Meibomian Gland ◽  
Tear Fluid ◽  
Immune Disorders ◽  
Dry Eyes ◽  
Online Portal ◽  
History Of

Eye dry syndrome or dry eye is a multifactorial disorder that causes reduced tear fluid, causing discomfort to the eye. Several risk factors that cause dry eye such as history of medication, meibomian gland dysfunction, age, gender, systemic disease and immune disorders (Mark, et al., 2021). Diabetes mellitus is one of the risk factors for dry eyes. The International Dry Eye Workshop II (DEWS) divides dry eyes into two parts based on etiopathological criteria, namely due to lack of tear production or Aqueous Tear Deficiency (ATD) and excessive evaporation or Evaporative Tear Deficiency (ETD) (shimazaki, 2018). Prevalence This article aims to review Diabetes Miletus, one of the risk factors for dry eye. The source search was carried out on the online portal of the publication of the journal Nation Center for Biotechnology Information / NCBI, Google Scholar with the keywords "Eye Dry Syndrome, Diabetes Milletus, Eye Dry treatment".

scholarly journals Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease Due to Meibomian Gland Disease

2017 ◽  
Vol 33 (9) ◽  
pp. 678-685 ◽  
Author(s):  
Philipp Steven ◽  
Albert J. Augustin ◽  
Gerd Geerling ◽  
Thomas Kaercher ◽  
Florian Kretz ◽  
...  
Keyword(s):  
Dry Eye ◽  
Meibomian Gland ◽  
Dry Eye Disease ◽  
Eye Disease ◽  
Eye Drops ◽  
Meibomian Gland Disease

Serum Retinol and β-carotene Levels and Risk Factors for Cardiovascular Disease in Morbid Obesity

2010 ◽  
Vol 80 (3) ◽  
pp. 159-167 ◽  
Author(s):  
Gabriela Villaça Chaves ◽  
Gisele Gonçalves de Souza ◽  
Andréa Cardoso de Matos ◽  
Dra. Wilza Abrantes Peres ◽  
Silvia Elaine Pereira ◽  
...  
Keyword(s):  
Risk Factors ◽  
Cardiovascular Disease ◽  
Metabolic Syndrome ◽  
Morbid Obesity ◽  
Serum Levels ◽  
World Health ◽  
Morbidly Obese ◽  
Serum Retinol ◽  
Significant Difference ◽  
Β Carotene

Objective: To evaluate retinol and β-carotene serum levels and their relationship with risk factors for cardiovascular disease in individuals with morbid obesity, resident in Rio de Janeiro. Methodology: Blood serum concentrations of retinol and β-carotene of 189 morbidly obese individuals were assessed. The metabolic syndrome was identified according to the criteria of the National Cholesterol Education Program (NCEP) and World Health Organization (WHO). Lipid profile, insulin resistance, basal insulin, glycemia, blood pressure, and anthropometry and their correlation with retinol and β-carotene serum levels were evaluated. Results: Metabolic syndrome diagnosis was observed in 49.0% of the sample. Within this percentage the levels of β-carotene were significantly lower when body mass index increased. Serum retinol didn't show this behavior. Serum retinol inadequacy in patients with metabolic syndrome (61.3%), according to WHO criterion, was higher (15.8%) than when the whole sample was considered (12.7%). When metabolic syndrome was diagnosed by NCEP criterion, β-carotene inadequacy was higher (42.8%) when compared to the total sample (37.5%). There was a significant difference between average β-carotene values of patients with and without metabolic syndrome (p=0.048) according to the classification of the NCEP. Lower values were found in patients with metabolic syndrome. Conclusion: Considering the vitamin A contribution in antioxidant protection, especially when risk factors for cardiovascular disease are present, it is suggested that great attention be given to morbidly obese. This could aid in prevention and treatment of cardiovascular disease, which affects a significant part of the population.

Sign in / Sign up

Export Citation Format

Share Document